Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Go back to Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
(NASDAQ: ACHV) Delayed: 5.01 --0 (-0%)
Previous Close $5.01    52 Week High
Open $5.01    52 Week Low
Day High $5.01    P/E N/A 
Day Low $5.01    EPS
Volume 636